Literature DB >> 2892478

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.

R J Baldessarini1, B M Cohen, M H Teicher.   

Abstract

The clinical use of antipsychotic agents may be enhanced by considering their dose-effect characteristics. In particular, assessment of immediate and later follow-up treatment of psychotic patients (1) indicates that moderate doses are adequate for most patients, (2) fails to support the utility of unusually high doses, and (3) even suggests the existence of a biphasic relationship of antipsychotic efficacy to dose of neuroleptics and possibly to plasma concentrations of the drugs as well. Trends toward lesser overall clinical benefits of high doses may reflect untoward extrapyramidal or other central nervous system effects leading to behavioral and cognitive symptoms. Thus, moderate doses of neuroleptics appear, on average, to be about as effective as, and probably safer than, the larger doses that have been popular in the United States in recent years.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2892478     DOI: 10.1001/archpsyc.1988.01800250095013

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  67 in total

Review 1.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

Review 2.  Past and present progress in the pharmacologic treatment of schizophrenia.

Authors:  John M Kane; Christoph U Correll
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

Review 3.  Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Authors:  Gary Remington
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

4.  Use of electronic medical record data for quality improvement in schizophrenia treatment.

Authors:  Richard R Owen; Carol R Thrush; Dale Cannon; Kevin L Sloan; Geoff Curran; Teresa Hudson; Mark Austen; Mona Ritchie
Journal:  J Am Med Inform Assoc       Date:  2004-06-07       Impact factor: 4.497

Review 5.  Dose response and atypical antipsychotics in schizophrenia.

Authors:  Bruce J Kinon; Jonna Ahl; Virginia L Stauffer; Angela L Hill; Peter F Buckley
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  New antipsychotic agents are much awaited.

Authors:  Arnob Chakraborti
Journal:  BMJ       Date:  2006-06-24

Review 7.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 8.  [Pharmacotherapy for schizophrenia].

Authors:  W W Fleischhacker; W Hummer
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

9.  Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

Authors:  L A Dunn; G E Atwater; C D Kilts
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Chronic antipsychotic treatment: protracted decreases in phospho-TrkA levels in the rat hippocampus.

Authors:  Alvin V Terry; Debra A Gearhart; Anilkumar Pillai; Guodong Zhang; Michael G Bartlett
Journal:  Int J Neuropsychopharmacol       Date:  2010-01-11       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.